|
Robert
Aris
|
|
|
Degrees
|
![]() |
|
Office:
4131 Bioinformatics |
|
|
Research Interests: 1) Clinical research in the area of lung transplantation (including post transplant osteoporosis, PTLD, infections related to B. cepacia and panresistant organisms, and obliterative bronchiolitis) 2) Basic mechanisms of chronic lung allograft rejection 3) Studies of the pathogenesis and treatment of bone disease in cystic fibrosis |
|
|
Aris RM, Lester G, Dingman S, Ontjes DA. Altered calcium
homeostasis in adults with cystic fibrosis. Osteoporosis International
1999; 10 (2):102-8. Neuringer IP, Walsh S, Mannon R, Gabriel S, and Aris RM. Enhanced
T-cell cytokine gene expression in mouse airway obliterative bronchiolitis.
Transplantation 2000; 69: 399-405. Aris RM, Lester GE, Renner JB, Winders AW, Blackwood AD, Lark
RK, and Ontjes DA. Efficacy of pamidronate for osteoporosis in cystic
fibrosis patients following lung transplantation. Am J Respir Crit
Care Med, 2000, 162: 941-6. Aris RM, Stevens A, Ontjes DA, Blackwood AD, Lark RK, Hensler
M, Neuringer IP, Lester GE. Adverse alterations in bone metabolism are
associated with lung infection in adults with cystic fibrosis. Am J
Respir Crit Care Med, 2000, 162(5):1674-1678. Yankaskas JR and Aris RM. Outpatient Care of Cystic Fibrosis Patient
after Lung Transplantation. Curr Opin in Pulm Med. 2000 Nov;6(6):551-7. Gilbey JG, Chalermskulrat W, and Aris RM. Aspergillus endocarditis
in a lung transplant recipient: case report and review of the transplant
literature. Annals of Transplantation 2000;5(3):48-53. Lark RK, Lester GE, Ontjes DA, Blackwood AD, Hollis BW, Hensler MM, Aris
RM. Diminished and erratic absorption of ergocalciferol in adult cystic
fibrosis patients. Am J Clin Nutr. 2001 Mar;73(3):602-606. Aris RM, Routh JC, LiPuma J, Heath D, Gilligan PH. Lung transplantation
for cystic fibrosis patients with Burk-holderia cepacia complex: survival
linked to genomovar type. Am J Respir Crit Care Med. 2001;164:2102-6. Aris RM. Complications after lung transplantation: Clues to diagnosis.
J Crit Ilness 2001. Aris RM, Ontjes DA, Buell HE, Blackwood AD, Lark RK, Brown SA,
Caminiti M, Chalermskulrat W, Renner JB, Lester GE. Abnormal bone turnover
in cystic fibrosis adults. Osteoporosis Int 2002;13(2):151-7. Heath DG, Hohneker K, Curriker C, Smith K, Routh J, LiPuma JJ, Aris
RM, Weber D, Gilligan PH. A six-year molecular analysis of Burkholderia
cepacia isolates among cystic fibrosis patients at a referral center for
lung transplantation. J Clin Microbiol. 2002 Apr;40(4):1188-1193. Neuringer IP, Aris RM, Chalermskulrat W, Burns K, and Randell,
SH. Epithelial Cell Kinetics in Mouse Tracheal Allografts. Am J Transplantation.
2002; 2: 410-9. Aris RM, Walsh SP, Chalermskulrat W, Hathwar VS and Neuringer
IP. Growth factor upregulation during obliterative bronchiolitis in the
mouse model. Am J Respir Crit Care 2002 Aug 1;166(3):417-22. Aris RM. Pathogenesis of bone disease in cystic fibrosis. Ped
Pulmonol 2002; suppl 24; 177-8. Egan T, Detterbeck F, Mill M, Bleiweis M, Aris R, Paradowski L,
Retsch-Bogart G, Mueller B. Long term results of lung transplantation
for cystic fibrosis . Eur J Cardiothorac Surg 2002 Oct;22(4):602 Chalermskulrat W, Neuringer IP, Brickey J, Randell SH, Felix N, Ting JP, Aris RM . Hierarchical Contributions of Allorecognition Pathways in Chronic Lung Rejection. Am J Respir Crit Care Med 2003;167:999-1007. Chalermskulrat W, Neuringer IP, Schmitz J, Gurka M, Randell S, Aris RM . HLA mismatching predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation. Chest 2003; 123: 1825-31. Brown SA, Ontjes DA, Lark RK, Blackwood AD, Hensler M, Caminiti M, Aris
RM. Short-term calcitriol administration improves calcium homeostasis
in adults with CF. Osteoporosis Int June 14(5): 442-9. Aris RM , Brown SA, Ontjes DA, Chalermskulrat W, Neuringer IP, Lester GE. Reduced Carboxylated Osteocalcin Levels in Cystic Fibrosis. Am J Respir Crit Care Med 2003 Nov 1;168(9):1129. Aris RM , Lester GE, Camaniti M, Blackwood AD, Hensler M, Lark RK, Hecker TM, Renner JB, Guillen U, Brown SA, Neuringer IP, Chalermskulrat W, Ontjes DA. Efficacy of Alendronate in Cystic Fibrosis Adults with Low Bone Density. Am J Respir Crit Care Med 2004; 169: 77-82. Hecker TM, Aris RM . Management of osteoporosis in adults with cystic fibrosis. Drugs 2004; 64 (2): 133-147. Charlermskulrat W, Neuringer IP, Park RCW, Brickey WJ, Braekman R, Randell SH, Aris RM . PX3.102, a Novel Chinese Herb Extract, Diminishes Chronic Airway Allograft Rejection. Transplantation2004 Jul 15;78(1):158-161. Tullis E, Aris R . Timing of Referral for Lung Transplant: Coordination Between the CF Center and Lung Transplantation Centers . Ped Pulmonol 2004; Supplement September 27; 176-7. Aris RM , Lester GE, Ontjes DA. Treatment of bone disease in cystic fibrosis. Curr Opin in Pulm Med. 2004 Nov;10(6):524-30. Aris RM , Donohue JF, Ontjes DA. Inhaled corticosteroids and fracture risk: Having our cake and eating it too. Chest 2005; 127(1): 5-7. Aris RM , Guise TA. Cystic Fibrosis and Bone Disease: Are We Missing a Genetic Link? Eur Respir J. 2005 Jan;25(1):9-11. Aris RM , Merkel PA, Bachrach LK, Borowitz DS, Boyle MP, Elkin SL, Guise TA, Hardin DS, Haworth CS, Holick MF, Joseph PM, O'Brien K, Tullis E, Watts NB, White TB. Invited Review of a consensus conference report: Guide to Bone Health and Disease in Cystic Fibrosis. J Clin Endocrinol Metab Epub 12/21/04 . Neuringer IP, Charlermskulrat W, Aris RM . Obliterative Bronchiolitis: Basic mechanisms of chronic lung rejection. J Heart Lung Transplant 2005; 24:3-19. Van Deventer HW, O'Connor W, Brickey WJ, Aris RM , Ting JPY, Serody JS. Chemokine Receptor 5 (CCR5) Promotes Pulmonary Metastasis. Cancer Res 2005. Apr 15;65(8):3374-9. Neuringer IP, Chalermskulrat W, Aris RM . Special problems in long-term survivors of lung transplantation. Pulmonary and Critical Care Update (PCCU) volume 19, lesson 11, http://www.chestnet.org/education/online/. Dua S, Chalermskultat W, Giligan P, Aris RM . Bilateral Pseudomonas endopthalmitis in a cystic fibrosis patient after lung transplantation. (Am J Transplant, In Press). Snell G, Valentine V, Vitulo P, Glanville A, McGiffin D, Roman A, Aris RM , Sole A, Hmissi A, Li A, Mayer H, Jaffe J, Pirro U. Everolimus vs azathioprine as adjunctive immunosupressive therapy to inhibit the decline of pulmonary function in stable lung or heart/lung transplant recipients: 12 and 24-Month Results of an International, Randomized, Double-Blind Study. Am J Transplant (under final review).
|
|